Cell Lysis and Disruption Market SWOT Analysis, Future Growth, Major Opportunity and Forecast 2030

Ryder Dean16 Nov, 2022Business

The expanding biotechnology and biopharmaceutical sector are driving the growth of this market. For instance, firms in the U.S. firms perform extensive RD in pharmaceuticals which is approximately USD 75 billion. The market is dominated by numerous established players. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, in June 2018, Thermo Fisher Scientific acquired Gatan, Inc. from Roper Technologies for approximately USD 925 million.